Glycogen phosphorylase as a potential target for design of new drugs for the treatment of diabetes mellitus type 2, its main role and functions, as well as the ligands that bind to different sites of the enzyme are discussed in this review.
No takes yet. Share an insight, caveat, or question.
Спасов et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: